Union announce offseason roster moves, part with Leon Flach
SAN DIEGO , Dec. 11, 2024 /PRNewswire/ -- BSD Builders, Inc., a general contractor specializing in healthcare construction, has announced a strategic partnership with 2G Energy Inc., a pioneer in energy systems, including cogeneration. The collaboration will focus on designing and deploying cutting-edge microgrid solutions to enhance energy resilience, sustainability, and efficiency for commercial building clients. The partnership was formed in response to the challenges faced by skilled nursing facilities during the California wildfires of 2018 and 2020. Utility companies initiated Public Safety Power Shutoffs (PSPS) during dangerous weather conditions, forcing facilities to evacuate patients. "After several of our skilled nursing clients were impacted by California wildfires, we worked on a solution to provide an alternative source of power so the lives of their vulnerable residents would not be at risk," explained Jeff Blair , CEO of BSD Builders, Inc. "We reached out to several energy infrastructure companies to support this initiative and were surprised that there was little interest. When we connected with the team at 2G Energy, Inc., they were not only amenable but enthusiastic to help find a way to help protect patients' health and safety." In 2022, California Governor Gavin Newsom passed legislation requiring skilled nursing facilities to maintain at least 96 hours of backup power. The BSD SSC Microgrid solution was developed not only to help skilled nursing facilities meet this new mandate but also to provide any building with a reliable and efficient source of power during outages. It was designed to withstand hurricane wind loads up to 150 mph and has been seismically certified (California OSHPD/HCAi OSP-0826). "Partnering with BSD Builders allows us to bring microgrid technology to people who need it most," said Darren Jamison , Managing Director of 2G Energy North America. "Microgrids are crucial for both enhancing energy security and reducing carbon footprints, and we are thrilled to collaborate on projects that not only drive innovation but also promote a more sustainable energy future." The first projects under the partnership are expected to be deployed in California , with plans to expand to additional markets in the coming months. The partnership underscores both companies' commitment to sustainability and their shared vision of reshaping the future of energy. For more information on BSD Builders, Inc. and 2G Energy Inc., or to inquire about the microgrid solutions, please visit bsdbuilders.com . About BSD Builders, Inc. - BSD Builders, Inc. is a leading general contractor specializing in the healthcare industry. Focusing on exceeding industry standards and delivering exceptional value to clients, BSD Builders, Inc. continues to set the benchmark for excellence in the construction and energy sectors. About 2G Energy Inc. - 2G Energy is a globally recognized leader in the development and production of combined heat and power (CHP) systems. With a commitment to sustainability and innovation, 2G Energy provides cutting-edge solutions that optimize energy efficiency and environmental performance. View original content to download multimedia: https://www.prnewswire.com/news-releases/bsd-builders-inc-partners-with-2g-energy-inc-to-develop-advanced-microgrid-solutions-302329485.html SOURCE BSD Builders, Inc.AP Trending SummaryBrief at 6:13 p.m. ESTFormer Blue Jays win multi-million-dollar tax battle against Canadian government
A week after giving up 19 unanswered second-half points to the Detroit Lions, the Texans' defense rebounded in a big way last week by holding the Cowboys to just one touchdown in a blowout Monday night victory. Cornerback Derek Stingley Jr was at the forefront of Defensive Coordinator Matt Burke’s success, finishing with two passes broken up, two tackles, and his second interception of the year. The debate rages around who the NFL’s best cornerback is, and while fans remain divided, the cast on KPRC’s Texans Pep Talk , unsurprisingly, think Stingley is top of the class. “You have to consistently win against the top guys to be considered a top cornerback,” DJ Bien-Aime said on Saturday’s show. “He’s done that against CeeDee Lamb, he’s done that against Amari Cooper in a playoff game, D.J. Moore. The list kind of goes on and on.” Just dropped an hour ago. Here’s us talking about how well CB Derek Stingley Jr. is playing right now. QBs have a passer rating of 61 when targeting Stingley. 8th lowest among CBs with at least 200 coverage snaps. https://t.co/Eg7IiSH7ss https://t.co/IpnSRdB1GL pic.twitter.com/aMJnXJau2s Now in his third year after being selected No. 3 overall in the 2022 Draft, Stingley’s two interceptions don’t compare with some of the top safeties in the league – or even fellow teammate Calen Bullock, who’s recorded four on the year. But when it comes to his position, Stingley’s two picks match one of the NFL’s top-paid cornerbacks in Jaire Alexander and leave him only one behind the other top contender, Patrick Surtain II. After signing a four-year, $96 million extension to reset the cornerback market during the offseason, Surtain is widely regarded as the best at his position, currently leading the league in interception yards with 128. Stingley reenters the argument though when you consider he ranks third to only Cleveland’s Denzel Ward and Detroit’s Brian Branch in passes defended (12), and rarely receives any safety help against the league’s best receivers. “The Jets game still sticks in my mind. No safety help going against Davante Adams, Garrett Wilson – he's been over 1,000 yards every single year in his career – Mike Williams, we know what he does. He was able to hold all three of those guys to three catches and 22 yards, no big plays, no explosives,” Bien-Aime went on to say. With the Titans ahead this week, Stingley may not have a better opportunity to record another interception against the turnover-prone Will Levis.
San Jose Sharks, who host Los Angeles Kings on Monday, activate center Nico Sturm off injured reserve
None
MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuardTM Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced the appointment of accomplished medical technology executive Scott R. Ward to its Board of Directors. Mr. Ward most recently served as Chief Executive Officer and President of Cardiovascular Systems, Inc. prior to its acquisition by Abbott (NYSE: ABT) in April 2023. Paul Stuka, Chairman of the Board of InspireMD, stated, “We are extremely fortunate to add Scott to what I consider to be a world-class Board of Directors. With his extensive operational experience and track record in the cardiovascular space, his insights will be invaluable as the Company rapidly approaches potential U.S. approval of CGuard Prime, the most significant value inflection point in its history. I look forward to Scott’s contributions and believe he will have an immediate impact.” Marvin Slosman, Chief Executive Officer of InspireMD and Board member, commented, “The addition of Scott to our Board adds tremendous experience in the cardiovascular field, with a track record of growth and innovation as an executive, a board member and investor. His experience and legacy in the space will help guide us through our next stages of advancing our novel carotid platform as part of a comprehensive approach to catalyzing on the market shift toward a stent first standard while also guiding our pipeline of innovation, including our CAS, TCAR and Neuro focus.” “I am very excited to join the InspireMD Board at such a transformational time for the company,” added Mr. Ward. “With an impressive body of data demonstrating the superior short- and long-term patient outcomes of its novel CGuard Prime carotid stent system, I believe that CGuard, when approved in the U.S., will quickly become a new standard-of-care for carotid intervention and stroke prevention. I look forward to working with my fellow Board members and the InspireMD leadership team to achieve this goal.” Mr. Ward has over 40 years of experience in the healthcare industry, including nearly 30 years at Medtronic, Inc. where he served in various leadership roles including as Senior Vice President and President of the CardioVascular, Neurological and Diabetes businesses. Mr. Ward is the Founder of Raymond Holdings, a firm with activities in venture capital, strategy and transactional advisory services for medical technology and life science companies. He earned his Bachelor of Science in Genetics and Cell Biology, his Master of Science in Toxicology, and his Master of Business Administration, all from the University of Minnesota. About InspireMD, Inc. InspireMD seeks to utilize its proprietary MicroNet ® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com . Forward-looking Statements This press release contains “forward-looking statements.” Forward-looking statements include, but are not limited to, statements regarding InspireMD or its management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential”, “scheduled” or similar words. Forward-looking statements include, but are not limited to, statements regarding InspireMD or its management team’s or directors’ expectations, hopes, beliefs, intentions or strategies regarding future events, future financial performance, strategies, expectations, competitive environment and regulation, including potential U.S. commercial launch.. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the company’s control, and cannot be predicted or quantified and consequently; actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with our history of recurring losses and negative cash flows from operating activities, significant future commitments and the uncertainty regarding the adequacy of our liquidity to pursue our complete business objectives, and substantial doubt regarding our ability to continue as a going concern; our need to raise additional capital to meet our business requirements in the future and such capital raising may be costly or difficult to obtain and could dilute our stockholders’ ownership interests; market acceptance of our products; an inability to secure and maintain regulatory approvals for the sale of our products; negative clinical trial results or lengthy product delays in key markets; our ability to maintain compliance with the Nasdaq listing standards; our ability to generate revenues from our products and obtain and maintain regulatory approvals for our products; our ability to adequately protect our intellectual property; our dependence on a single manufacturing facility and our ability to comply with stringent manufacturing quality standards and to increase production as necessary; the risk that the data collected from our current and planned clinical trials may not be sufficient to demonstrate that our technology is an attractive alternative to other procedures and products; intense competition in our industry, with competitors having substantially greater financial, technological, research and development, regulatory and clinical, manufacturing, marketing and sales, distribution and personnel resources than we do; entry of new competitors and products and potential technological obsolescence of our products; inability to carry out research, development and commercialization plans; loss of a key customer or supplier; technical problems with our research and products and potential product liability claims; product malfunctions; price increases for supplies and components; insufficient or inadequate reimbursement by governmental and other third-party payers for our products; our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful; adverse federal, state and local government regulation, in the United States, Europe or Israel and other foreign jurisdictions; the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction; the escalation of hostilities in Israel, which could impair our ability to manufacture our products; and current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. Investor Contacts: Craig Shore Chief Financial Officer InspireMD, Inc. 888-776-6804 craigs@inspiremd.com Chuck Padala, Managing Director LifeSci Advisors 646-627-8390 chuck@lifesciadvisors.com investor-relations@inspiremd.comNoneGovt warns PTI against bringing 'armed groups' to Islamabad
No. 14 Kentucky women roll past Arizona State with scoring and rebounding balance 77-61A robot (left) inspects operations at a net-zero emissions data center in Haidong, Qinghai province.(LI JUN/CHINA NEWS SERVICE) China plans to complete construction of a national data infrastructure by 2029, while establishing a public data service system and data operation mechanism, according to a draft guideline published by the National Data Administration on Friday. The move is part of the country's broader push to facilitate the circulation of data, bolster the application and development of data resources, lay a solid foundation for the growth of the digital economy and advance the building of a "Digital China", the administration said. The draft guideline states that efforts will be made to finish the top-level design of a national data infrastructure between 2024 and 2026, and to build an infrastructure that supports large-scale data circulation and interconnectivity, while fully integrating data networks and computing power facilities between 2027 and 2028. China will optimize and upgrade traditional network facilities, push ahead with 5G-A deployments from 5G, as well as speed up the research and development of 6G technology, the guideline states. 5G-A refers to 5G advanced technology, a crucial upgrade to the 5G network in functionality and coverage. Data infrastructure means a new type of infrastructure that provides data collection, aggregation, transmission, processing, circulation, utilization, operation and security services. It integrates hardware, software, model algorithms, standards and specifications and mechanism design. The authority is asking for public opinion on the guideline through Dec 1. "China's emphasis on the establishment of a national data infrastructure by 2029 is of great significance in promoting the high-quality development of the country's digital economy and unleashing the value of massive data resources," said Zhu Keli, founding director of the China Institute of New Economy. The move is conducive to not only promoting the effective integration and efficient use of data resources, but also to bolstering the circulation of data, Zhu said, adding that through the construction of a public data service system, the mobility and allocation efficiency of data elements are expected to be elevated significantly, thus injecting new vitality into the digital economy. Meanwhile, it will help propel deeper integration of data elements with the real economy, boost the transformation and upgrading of traditional industries, and cultivate new economic growth drivers, while attracting more social capital and resources to invest in the digital economy domain, Zhu added. The guideline also calls for a heightened push to promote the circulation of data in a reliable manner, improve the supply of computing power resources, boost high-speed and efficient transmission of data, and ensure data security. Data has become a new type of production factor and is playing an increasingly vital part in bolstering industrial digitalization, said Pan Helin, a member of the Expert Committee for Information and Communication Economy, which is under the Ministry of Industry and Information Technology. "The construction and operation of a national data infrastructure is crucial for promoting the circulation, trading and utilization of data elements, building the basic systems for data, cultivating a national integrated data market, and nurturing the new quality productive forces," Pan said. Moreover, the country will step up efforts to strengthen the classified management and protection of data; establish a high-quality data supply system covering public data, enterprise data and individual data; support the development of public service platforms for data circulation and trading; as well as expand application scenarios of data elements in key industries, the NDA said.
Donald Trump will ring the New York Stock Exchange bell as he's named Time's Person of the YearMEXICO CITY (AP) — Mexico has been taking a bashing lately for allegedly serving as a conduit for Chinese parts and products into North America, and officials here are afraid a re-elected Donald Trump or politically struggling Canadian Prime Minister Justin Trudeau could try to leave their country out of the U.S.-Mexico-Canada free trade agreement. Mexico’s ruling Morena party is so afraid of losing the trade deal that President Claudia Sheinbaum said Friday the government has gone on a campaign to get companies to replace Chinese parts with locally made ones. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
After 45 years, authorities in California were finally able to tell the Gonzalez family who they believe killed their loved one. The Riverside County Sheriff’s Office used DNA and forensic genealogy to identify the suspected killer, who turned out to be the same man who reported finding Esther Gonzalez’s body to authorities. On Feb. 9, 1979, 17-year-old Gonzalez was walking to her sister's house in Banning, California, about 85 miles east of Los Angeles. She never made it home. The next day, her body was found in a snowpack off a highway near Banning, the Riverside County District Attorney’s Office said in a news release . She was attacked during her walk, raped and bludgeoned to death, authorities said. Deputies described the unidentified man who found the body as "argumentative," according to the news release. The man, later identified as Lewis Randolph "Randy" Williamson, called the county sheriff to report the body and said he didn't know whether it was a man or woman. Williamson was later asked by sheriff's investigators to take a polygraph test. The district attorney's office said he agreed to the test and passed, which "at the time, cleared him of any wrongdoing," according to the release. Nearly five decades later, the district attorney's office said a cold case homicide team used forensic genealogy to confirm Williamson is Gonzalez's suspected killer. Forensic genealogy is surging across the country as investigators analyze DNA in addition to traditional genealogy research to generate leads for unsolved cases. Jason Corey, the master investigator for the Riverside County Sheriff’s Office, said the technique is a tremendous addition to an investigator’s toolbox. "I think it will be a great investigative tool moving forward in the future," Corey said. "It will help do a lot of good and not only identify victims, but it will help point the investigators in a direction with their investigative leads that will help bring those suspects to justice." Even as the Gonzalez case went cold, Riverside County detectives kept searching. The homicide team continued to investigate the case for decades after Gonzalez’s death. The team uploaded a semen sample from the crime scene into the Combined DNA Index System, but there weren't any leads. In 2023, detectives sent various items of evidence to a genetic lab in Texas that specializes in forensic genealogy and identifying victims in unsolved murders. Earlier this year, a crime analyst laid out all the facts of the case. Then, the light bulb went off. "Although Williamson was seemingly cleared by the polygraph in 1979, he was never cleared through DNA because the technology had not yet been developed," the district attorney's office said. Conducting another polygraph was not an option, as Williamson died in Florida in 2014. However, a blood sample had been collected during his autopsy. Authorities in Florida sent the sample to the California Department of Justice, which confirmed Williamson's DNA matched the DNA semen sample recovered from Gonzalez's body. Corey said this case was in Riverside County's cold case unit since it launched about five years ago. Over the years, multiple investigators have worked on the case. That all came to an end this Wednesday. "I can't imagine what it’s like for them," Corey said. "That whole family has just been devastated over the years. This is a day-in and day-in, day-out thing. I don’t think this is something that ever got easier for them as time went on." "I don't know if you can say you're happy that it's done because it's still, it's still a terrible tragedy, but I hope it can bring them some closure," Corey said. The latest development in the cold case does bring peace and closure to the Gonzalez family, Esther's older sister Elizabeth said. She was happy to hear her sister's suspected killer was finally identified. "We are very happy that we finally have closure," Elizabeth Gonzalez, 64, wrote in an email to CNN. "We are happy about it, but since the guy has died, a little sad that he won’t spend any time for her murder." Esther and Elizabeth Gonzalez grew up very close as they were only one year apart in age. Esther is now remembered by her family for her shy yet funny and mild-mannered personality. She the fourth out of seven children. Esther's oldest brother, Eddie, wrote on Facebook , "The Gonzalez family would like to thank the Riverside County sheriff’s department on a job well done. After 40 years, the Gonzalez family has closure."(BPT) - This article was sponsored and developed by Neurocrine Biosciences, Inc. Cerebral palsy (CP) is a neurodevelopmental disorder affecting movement and posture that begins in early childhood development. It is the most common cause of motor disability in children, affecting about one in 345 children in the United States. 1-2 It may happen as a result of lack of oxygen during or around birth, stroke, infection, a problem with metabolism or other problems that cause injury or affect the development of parts of the brain involved in movement control in the first few years of life. 3 CP is a permanent condition, affecting a person for their entire life. People living with CP typically have motor problems, which may include spasticity (abnormal muscle tightness), dyskinesia (uncontrolled movements) or ataxia (poor muscle control), and many people have a mix of these motor disorders. 4 Dyskinesia due to CP (DCP) is one of the most disabling forms of CP and impacts approximately 10% to 20% of people living with CP. 5-6 According to the Cerebral Palsy Foundation (CPF), the combination of irregular and unpredictable movements (chorea) and twisting and repeating movements (dystonia) often disrupt activities and cause significant functional impairment, including the ability to maintain balance, walk or fine motor control. 7 Heather Riordan, M.D., Neurologist and Movement Disorders Specialist, Director of the Phelps Center for Cerebral Palsy at the Kennedy Krieger Institute, discusses the symptoms of chorea and impact on patients in a video shared on the CPF website here . About 30% of people with DCP are affected mostly by these involuntary and irregular movements (chorea), while dystonia is the predominant motor finding in the remaining 70%. 8 However, it is common for both chorea and dystonia movements to be present together. 6 For people living with DCP, these movements can occur in any region of the body, including the arms and legs, torso and face and may vary in severity. They are often triggered or made worse by stimulation or stress. Because dyskinesia can occur at rest and/or when actively using the body, the problems with movement are very burdensome in day-to-day living, with discomfort and pain affecting the quality of life for people and their caregivers. 9 Jen Lyman, mom to a son with DCP, highlights how dyskinesia makes communicating more difficult. "The most difficult thing about dyskinesia is watching my son struggle to do things that he wants to do, but the extra movements get in the way...special things, such as using a touch screen to video chat with his grandmother, are nearly impossible despite his best efforts to use his hands and fingers. Something so simple, yet so special for him should be effortless." DCP has a wide-ranging impact on the individual, including lifelong challenges with movement, a higher risk of other medical issues, a higher rate of mental health challenges and difficulties with communication. 10-12 "Those of us who have the privilege to serve patients with dyskinetic, hyperkinetic or mixed cerebral palsy see the functional impact of this very challenging type of tone every day," said Susan Biffl, M.D., Rehabilitation Medicine Specialist at Rady Children's Hospital-San Diego and Assistant Professor at UC San Diego School of Medicine. "Patients face challenges with self-care, independence, mobility, communication, fine motor skills that affect occupational and recreational activities, swallowing, social interactions and even sleep. As this tone is variable, it is much more challenging to treat than more consistent tone issues, such as spasticity." Treatment Options There are currently no Food and Drug Administration-approved treatments for DCP. Dystonia and chorea are often managed separately as they respond differently to various treatments, which can make treatment challenging. 3 Most drugs being investigated for DCP have focused on dystonia, and more research is needed to determine potential treatments for chorea. New treatment options are needed to help manage these movement disorders and improve daily function and quality of life for those affected. "After 20 years of caring for individuals with cerebral palsy, I continue to find those with dyskinetic cerebral palsy among the most challenging to treat, largely due to the limited effectiveness of available pharmacologic options," said Joyce Oleszek, M.D., Professor, Department of Physical Medicine and Rehabilitation, University of Colorado School of Medicine. "There is an urgent need for more robust evidence to support pharmacologic treatments for this condition, given its profound impact on function, comfort and quality of life." Ongoing Research Clinical studies are important in the development of treatment options, allowing researchers to evaluate the safety and effectiveness of new medicines. The data from clinical studies are used to determine if an investigational treatment can be approved for use to treat certain disorders. There are ongoing clinical studies evaluating potential treatments for DCP, including one for chorea. Neurocrine Biosciences is conducting the KINECT ® -DCP clinical study, a Phase 3, randomized, double-blind placebo-controlled study investigating the study drug, valbenazine, for the treatment of DCP. The clinical study is currently enrolling children, adolescents and adults six to 70 years of age who have been diagnosed with DCP. "The Cerebral Palsy Foundation is excited to partner with Neurocrine Biosciences on this study," said Rachel Byrne, Executive Director of the Cerebral Palsy Foundation. "We are proud to support strong research that can potentially bring meaningful change to the lives of those living with cerebral palsy." If you or someone you know may be eligible for this research study, please visit the study website for additional information here: FindADCPStudy.com . REFERENCES © 2024 Neurocrine Biosciences, Inc. All Rights Reserved. CAP-NBI-US-0115 12/2024 NBI-98854-DCP3018_11DecMatRelease_v1.0_25November2024None
AP News Summary at 4:53 p.m. ESTAP News Summary at 6:10 p.m. ESTMONTRÉAL , Nov. 25, 2024 /PRNewswire/ -- Workleap , a leading Canadian software company behind products that empower 20,000 companies in more than 100 countries to build better employee experiences, announces its fall platform release introducing new solutions and integrated features into an all-in-one simple-to-use platform. This release marks a new milestone in Workleap's ongoing commitment to transform the employee experience by empowering HR leaders to drive organizational performance and achieve business goals. Workleap's comprehensive platform helps HR lead organizations to thrive in the modern setting of hybrid, remote, and distributed work environments. The consolidated solution for understanding employee engagement, driving performance, and developing employees is the best add-on to your existing HRIS and HR technology, allowing companies to add simple experiences across the employee lifecycle. Bringing these functions together in one platform, Workleap enables HR professionals to create a more responsive, agile and employee-centric work environment. What's New Why It Matters " Hybrid work has completely reshaped the role of HR. It's no longer just about managing employees—it's about building the right frameworks, fostering authentic connections, and leveraging tools that drive meaningful outcomes," said Simon De Baene , Co-founder and CEO of Workleap. "At Workleap, our mission is clear: make work simpler. The Workleap platform brings together the tools HR teams and leaders need to focus on what matters most—creating workplaces where people feel supported, connected, and empowered to grow. By continuing to invest in our platform, we're accelerating innovation with solutions like Workleap Performance—designed to be simple, effective, and built to keep HR and leaders ahead as the future of work evolves." To learn more about Workleap's employee experience platform, visit workleap.com . About Workleap Workleap is the best add-on to your HRIS to build better employee experiences. The all-in-one Workleap platform empowers organizations to make work simpler by unifying onboarding, engagement, performance, and development —in one platform. Workleap is a Montréal, Canada-based company building the operating system for hybrid work—unifying the experience to streamline talent management and scale productivity tools across 20,000 companies in more than 100 countries. Media Contact Jaclyn Pullen PANBlast for Workleap workleap@panblastpr.com View original content to download multimedia: https://www.prnewswire.com/news-releases/workleap-fall-launch-empowering-hr-leaders-with-new-features-for-employee-growth-and-engagement-302315807.html SOURCE Workleap
LAHAINA, Hawaii — Andrej Jakimovski converted an off-balance layup with 8 seconds left, and Colorado handed No. 2 UConn its second loss in two days at the Maui Invitational, beating the two-time defending national champion 73-72 on Tuesday. A day after a 99-97 overtime loss to Memphis that left Huskies coach Dan Hurley livid about the officiating, UConn (4-2) couldn’t shake the unranked Buffaloes (5-1), who shot 62.5 percent in the second half. With Colorado trailing 72-71 in the closing seconds, Jakimovski drove to his right and absorbed contact from UConn’s Liam McNeeley. He tossed the ball toward the glass and the shot was good as he fell to the floor. Hassan Diarra missed a 3-pointer just ahead of the buzzer for UConn. Elijah Malone and Julian Hammond III scored 16 points each for Colorado, and Jakimovski had 12 points and 10 rebounds. The Huskies, who entered the tournament on a 17-game winning streak, led 40-32 at halftime and by nine points early in the second half, but Colorado quickly closed that gap. McNeeley led UConn with 20 points.
Memphis fights off No. 2 UConn in OT in Maui Invitational thriller
Pat Bryant caught a 40-yard touchdown on fourth down with four seconds remaining as No. 25 Illinois rallied for a dramatic 38-31 victory over Rutgers on Saturday afternoon in Piscataway, N.J. With Rutgers playing cover-zero defense, Bryant caught Luke Altmyer's sidearm toss on fourth-and-13 at the 22-yard line in the middle of the field and ran in from the right side for a 36-31 lead. Bryant's dramatic catch came after Illinois initially decided to attempt a go-ahead 57-yard field goal into the wind. Following a timeout, the Ilini went for it on fourth down. Altmeyer's two-point conversion attempt to Bryant was incomplete, but the visitors recorded a safety on the game's final play. Bryant finished with seven catches for a career-high 197 yards, and his score came after Rutgers took a 31-30 lead on a 13-yard rushing TD by Kyle Monangai with 1:08 left. Monangai gave the Scarlet Knights the lead after Illinois overcame a nine-point deficit on Aidan Laughery's 8-yard TD run with 13:48 remaining and Altmyer's 30-yard run with 3:07 left. Bryant's clutch catch gave Illinois (8-3, 5-3 Big Ten) eight wins for the second time in three seasons on a day when it committed 11 penalties. Altmyer finished 12-of-26 passing for 249 yards and threw two touchdowns. He also gained a team-high 74 yards on the ground as the Ilini totaled 182 rushing yards. Monangai finished with 122 yards on 28 carries and Kaliakmanis completed 19-of-37 passes for 175 yards, but Rutgers (6-5, 3-5) was unable to win a third straight Big Ten game for the first time. Kaliakmanis also rushed for 84 yards and two touchdowns on 13 carries. The Scarlet Knights saw their losing streak against ranked teams reach 41 games after taking a 17-9 halftime lead and a 24-15 advantage early in the fourth. --Field Level MediaSharks make roster moves ahead of game vs. L.A. KingsNone
